Johnson & Johnson proposes $8.9 bn settlement of talc cancer claims
Headline from MedicalXpress, on the newest of 2 developments
US pharmaceutical giant Johnson & Johnson on Tuesday proposed an $8.9 billion settlement to resolve years-old lawsuits claiming that its talcum powder products caused cancer.
MedicalXpress's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Johnson & Johnson Proposes Paying $9 Billion to Settle Talc Lawsuits
Headline from Wall Street Journal ·
Newest
Johnson & Johnson proposes $8.9 bn settlement of talc cancer claims
Johnson & Johnson said it agreed to pay $8.9 billion to resolve all cancer lawsuits tied to its talc-based powders and will make a fresh attempt to contain the liability within a bankruptcy filing by one of its units.
US pharmaceutical giant Johnson & Johnson on Tuesday proposed an $8.9 billion settlement to resolve years-old lawsuits claiming that its talcum powder products caused cancer.
By David Goldman, CNN Johnson & Johnson is trying once again to use the bankruptcy courts to settle tens of thousands of cases that claim its talc products cause cancer. The pharmaceutical company is now willing to pay $8.9 billion to plaintiffs over 25 years.
WEDNESDAY, April 5, 2023 (HealthDay News) -- Tens of thousands of people suing Johnson & Johnson may get some relief after the company announced Tuesday that it will pay $8.9
Johnson & Johnson is offering nearly $9 billion to settle claims involving its talcum powder. The tentative deal has the backing of many people who sued the company, but not everyone.
NEW YORK — Health-care giant Johnson & Johnson (J&J) on Tuesday said it was setting aside $8.9 billion to resolve all claims related to its talc-based baby powder. J&J said
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Johnson & Johnson proposes $8.9 bn settlement of talc cancer claims | Since Then